The FDA announced on June 26, 2015, that American Health Packaging is recalling Desmopressin Acetate Tablets due to incorrect imprinting. Some tablets were imprinted with an X on one side instead of the correct identification.
How to tell if you have it
- Brand: American Health Packaging
- Product: Desmopressin Acetate Tablets, 0.1 mg
- NDC: 68084-606-21
- Lot #: 151360
- Expiry: 12/31/2016
- Quantity: 341 Cartons (3 x 10)
The hazard
The hazard involves tablets and capsules imprinted with the wrong identification. Specifically, some Desmopressin Acetate Tablets were incorrectly imprinted with an X on one side.
Context
GovInfoNow's records show American Health Packaging has 41 other recalls on record since July 23, 2012. Other recent recalls of similar products include American Health Packaging Buprenorphine Tablets Recall (Aug. 19, 2026), American Health Packaging Nitrofurantoin Capsules Recall (May 3, 2022), and American Health Packaging Recalls Cyanocobalamin Injection (April 12, 2022). Other recent recalls of similar products include Unichem Recalls Doxazosin 4mg Tablets (Jan. 21, 2026), American Regent Levocarnitine Injection Recall (April 16, 2026), and SpecGx Oxycodone/Acetaminophen Tablets Recall (Dec. 16, 2025).